Shopping Cart
- Remove All
- Your shopping cart is currently empty
Temelimab (GNbAC-1) is a monoclonal antibody targeting endogenous retroviruses in humans, used for studying multiple sclerosis (MS) and type 1 diabetes (T1D).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $486 | In Stock | |
5 mg | $1,350 | In Stock | |
10 mg | $1,830 | In Stock | |
25 mg | $2,690 | In Stock |
Description | Temelimab (GNbAC-1) is a monoclonal antibody targeting endogenous retroviruses in humans, used for studying multiple sclerosis (MS) and type 1 diabetes (T1D). |
In vitro | Temelimab was well tolerated and safe in vivo. [1] |
In vivo | No effects on clinical signs, body weight, food consumption, or pathology were observed in Temelimab (6 mg/kg and 30 mg/kg intravenously) mice. [1] |
Alias | GNN-001, GNN001, GNbAC-1, GNbAC1, GENHP-01, GENHP01 |
Cas No. | 1393641-34-3 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.